Cigarette smoking and invasive pneumococcal disease
By J. Nuorti, J. Butler, M. Farley, L. Harrison, A. McGeer, M. Kolczak, R. Breiman. 2000
773 citations recorded by the source corpus.
Subfields: Epidemiology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/95a61c1028bf3f709086605c16a87a488d7acf79
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pulmonary and Respiratory Medicine
Citations in the corpus
- Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults (2007, background): “Smoking is associated with a substantial risk of pneumococcal bacteremia; one report showed that smoking was the strongest of multiple risks for invasive pneumococcal disease in immunocompetent nonelderly adults [328].”
- Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent Adults (2003, background): “It is also associated with a substantial risk of pneumococcal bacteremia; one report showed that smoking was the strongest of multiple risks for invasive pneumococcal disease in immunocompetent, nonelderly adults [188].”
- Active bacterial core surveillance of the emerging infections program network. (2001, background): “A similar study of invasive pneumococcal disease in 18- to 64-year-old adults who were not immunocompromised identified active and passive smoking, in addition to household contact with a child in day care, as independent risk factors for disease (30).”
- BTS guidelines for the management of community acquired pneumonia in adults: update 2009 (2009, background): “499 [Ib] [Ib] Dose-response relationships with the current number of cigarettes smoked per day, pack-years of smoking and time since quitting have been demonstrated in relation to invasive pneumococcal disease.(500) [III]”
- The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation (2007, background): “These effects are in agreement with those studies suggesting that chronic exposure to nicotine provides a sustained anti-inflammatory potential that favors lung infections, such as pneumonia caused by S. pneumoniae, are more frequent in smokers (Nuorti et al., 2000).”